Dis-Chem Pharmacies Ltd
JSE:DCP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 825
3 888
|
Price Target |
|
We'll email you a reminder when the closing price reaches Zac.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dis-Chem Pharmacies Ltd
Total Equity
Dis-Chem Pharmacies Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
Total Equity
zar4.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
Dis-Chem Pharmacies Ltd
Glance View
Dis-Chem Pharmacies Ltd. is a prominent South African retail pharmacy chain that has carved out a significant niche in the healthcare market since its inception in 1978. Founded by the visionary couple, Ivan and Lynette Bronfeld, Dis-Chem has grown from a single store in Mondeor to a network of over 200 pharmacies nationwide, offering a comprehensive range of pharmaceutical products, health and beauty items, and wellness services. The company's commitment to customer service, affordability, and community engagement has established it as a trusted brand among South African consumers, creating a loyal clientele that continues to drive revenue growth. For investors, Dis-Chem represents a promising opportunity in the evolving healthcare landscape. The company has consistently demonstrated robust financial performance, with revenue growth propelled by its expansion strategy and an increasing focus on e-commerce. With a well-diversified product offering that includes private label goods and prescription medications, Dis-Chem is well-positioned to capitalize on the growing demand for health services in South Africa. Furthermore, the company’s strategic focus on operational efficiency and cost management enhances its profitability, making it a compelling choice for investors seeking exposure to the retail pharmacy sector in a dynamic economic environment.
See Also
What is Dis-Chem Pharmacies Ltd's Total Equity?
Total Equity
4.5B
ZAR
Based on the financial report for Feb 29, 2024, Dis-Chem Pharmacies Ltd's Total Equity amounts to 4.5B ZAR.
What is Dis-Chem Pharmacies Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
19%
Over the last year, the Total Equity growth was 15%. The average annual Total Equity growth rates for Dis-Chem Pharmacies Ltd have been 15% over the past three years , 19% over the past five years .